Dayoung Oh

Dr. Dayoung Oh

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2020 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
BSBo Shan
Bo Shan
MSMengle Shao
Mengle Shao
QZQianbin Zhang
Qianbin Zhang
CHChelsea Hepler
Chelsea Hepler
VPVivian A. Paschoal
Vivian A. Paschoal
RGRana K. Gupta
Rana K. Gupta

14 May 2020 in Cell Metabolism
Verified
Journal Article
Closed access
VPVivian A. Paschoal
Vivian A. Paschoal
EWEvelyn Walenta
Evelyn Walenta
STSaswata Talukdar
Saswata Talukdar
APAriane R. Pessentheiner
Ariane R. Pessentheiner
OOOlivia Osborn
Olivia Osborn
DODayoung Oh
Dayoung Oh

3 February 2021 in Cell Stem Cell
Verified
Journal Article
Closed access
NJNolwenn Joffin
Nolwenn Joffin
VPVivian A. Paschoal
Vivian A. Paschoal
CGChristy M. Gliniak
Christy M. Gliniak
CCClair Crewe
Clair Crewe
AEAbdallah Elnwasany
Abdallah Elnwasany
PSPhilipp E Scherer
Philipp E Scherer

23 August 2021 in Frontiers in Endocrinology
Verified
Journal Article
Open access
CSCamila Oliveira de Souza
Camila Oliveira de Souza
XSXuenan Sun
Xuenan Sun
DODayoung Oh
Dayoung Oh
Seven transmembrane receptors (7TMRs), often termed G protein-coupled receptors (GPCRs), are the most common target of therapeutic drugs used today. Many studies suggest that distinct members of the GPCR superfamily represent potential targets for the treatment of various metabolic disorders including obesity and type 2 diabetes (T2D). GPCRs typically activate different classes of heterotrimeric G proteins, which can be subgrouped into four major functional types: Gαs, Gαi, Gαq/11, and G12/13, in response to agonist binding. Accumulating evidence suggests that GPCRs can also initiate β-arrestin-dependent, G protein-independent signaling. Thus, the physiological outcome of activating a certain GPCR in a particular tissue may also be modulated by β-arrestin-dependent, but G protein-independent signaling pathways. In this review, we will focus on the role of G protein- and β-arrestin-dependent signaling pathways in the development of obesity and T2D-related metabolic disorders.

15 December 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
XSXue-Nan Sun
Xue-Nan Sun
YAYu An
Yu An
VPVivian A. Paschoal
Vivian A. Paschoal
CSCamila O. de Souza
Camila O. de Souza
MWMay-Yun Wang
May-Yun Wang
DODayoung Oh
Dayoung Oh
The G protein–coupled receptor 84 (GPR84), a medium-chain fatty acid receptor, has garnered attention because of its potential involvement in a range of metabolic conditions. However, the precise mechanisms underlying this effect remain elusive. Our study has shed light on the pivotal role of GPR84, revealing its robust expression and functional significance within brown adipose tissue (BAT). Mice lacking GPR84 exhibited increased lipid accumulation in BAT, rendering them more susceptible to cold exposure and displaying reduced BAT activity compared with their WT counterparts. Our in vitro experiments with primary brown adipocytes from GPR84-KO mice revealed diminished expression of thermogenic genes and reduced O2 consumption. Furthermore, the application of the GPR84 agonist 6-n-octylaminouracil (6-OAU) counteracted these effects, effectively reinstating the brown adipocyte activity. These compelling in vivo and in vitro findings converge to highlight mitochondrial dysfunction as the primary cause of BAT anomalies in GPR84-KO mice. The activation of GPR84 induced an increase in intracellular Ca2+ levels, which intricately influenced mitochondrial respiration. By modulating mitochondrial Ca2+ levels and respiration, GPR84 acts as a potent molecule involved in BAT activity. These findings suggest that GPR84 is a potential therapeutic target for invigorating BAT and ameliorating metabolic disorders.

6 November 2025 in Science
Verified
Journal Article
Closed access
CLChao Li
Chao Li
XSXue-Nan Sun
Xue-Nan Sun
JFJan-Bernd Funcke
Jan-Bernd Funcke
LVLauri Vanharanta
Lauri Vanharanta
XPXavier Prasanna
Xavier Prasanna
PSPhilipp E Scherer
Philipp E Scherer
The microprotein adipogenin (Adig) is predominantly expressed in adipose tissues. Here, we found that Adig interacts with seipin to form a stable, rigid complex. We present the structure of the seipin-Adig complex at an overall resolution of ~3.0 angstroms. The structure revealed that mammalian seipin assembles into two distinct oligomeric forms: undecamers and dodecamers. Adig selectively bound to the dodecameric form and enhanced seipin assembly by bridging and stabilizing adjacent subunits. Functionally, this complex promoted lipid droplet development at both early and late stages. In transgenic mice, adipocyte-specific overexpression of Adig increased fat mass and enlarged lipid droplets, whereas Adig deletion disrupted triglyceride accumulation in brown adipose tissues. Thus, Adig can modulate lipid storage through its structural and functional interactions with seipin.